Molecular Landscape of Complex Lifestyle Modification
COPMose
Metabolic Dysregulation as the Underlying Principle of Integrated Pathophysiology of Obesity-associated Chronic Diseases: Molecular Landscape of Complex Lifestyle Modification
1 other identifier
interventional
50
1 country
1
Brief Summary
The goal of this clinical trial is to detect the impact of the 3-month complex lifestyle intervention, consisting of dietary counselling, supervised exercise training and cognitive-behavioural intervention in middle-aged sedentary individuals with obesity, specific questions are:
- What is the adaptive response to exercise training on the whole-body and skeletal muscle energy metabolism, insulin sensitivity, metabolic flexibility, muscle functional parameters and cardiopulmonary fitness?
- Would the intensity-related changes of the exercise-induced substrate preference (lipids vs carbohydrates) be a good predictive marker of metabolic flexibility i.e. the capacity to reduce the whole-body metabolic burden in patients with obesity?
- Is the signal driving the adaptive response to regular exercise contained in serum derived Extracellular vesicles? Researchers will examine effects of exercise training intervention on whole body energy metabolism, by integrating clinical, biochemical and molecular data. Participants will:
- Undergo 3 months exercise - intervention program.
- Be submitted to examination of their obesity, energy metabolism and cardiopulmonary fitness related phenotypes using bioelectric impedance, indirect calorimetry, cycle spiroergometry.
- Blood samples will be taken both, at the baseline PRE- and POST- intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 15, 2024
CompletedFirst Submitted
Initial submission to the registry
March 30, 2025
CompletedFirst Posted
Study publicly available on registry
May 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
ExpectedMay 1, 2025
April 1, 2025
1 year
March 30, 2025
April 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Metabolic flexibility in response to submaximal exercise and nutritional challenge
Metabolic flexibility (metabolic substrate switching) will be measured using indirect calorimetry during submaximal exercise test (on stationary bike) and in response to nutritional challenge (fasting / glucose uptake during oGTT)
24 months
Secondary Outcomes (3)
cardiopulmonary fitness (VO2max)
24 months
Index of insulin resistance (oGTT)
24 months
abdominal adiposity and abdominal adipose tissue distribution (subcutaneous / visceral)
24 months
Study Arms (2)
lifestyle intervention
EXPERIMENTALControl
NO INTERVENTIONInterventions
Supervised lifestyle intervention will consist of regular exercise (3x a week), nutritional counselling (weekly), cognitive bahavioural therapy (monthly).
Eligibility Criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Slovak Academy of Scienceslead
- Medical University Viennacollaborator
Study Sites (1)
Center for Obesity Management EASO, Biomedical Research Center SAS
Bratislava, Bratislava Region, 84505, Slovakia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Barbara Ukropcová, Prof. MD PhD
Biomedical Research Center Slovak Acad Sci
- PRINCIPAL INVESTIGATOR
Jozef Ukropec, PhD, DSc
Biomedical Research Center Slovak Acad Sci
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD, DSc
Study Record Dates
First Submitted
March 30, 2025
First Posted
May 1, 2025
Study Start
December 15, 2024
Primary Completion
December 31, 2025
Study Completion (Estimated)
June 30, 2026
Last Updated
May 1, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR
- Time Frame
- 06/2026 (start date) indefinitely (end date)
- Access Criteria
- researchers with legitimate interest
Study protocol and SAP will be available upon study completion, and primary and secondary outcomes (clinical study report) will be shared after publishing the results in a scientific journal.